{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:52:26Z","timestamp":1754261546611,"version":"3.41.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T00:00:00Z","timestamp":1461801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00403-016-1649-4","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T16:49:51Z","timestamp":1461862191000},"page":"335-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH\/MAGL inhibitors produce antipruritic effect in mice"],"prefix":"10.1007","volume":"308","author":[{"given":"Ozgur","family":"Yesilyurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutlu","family":"Cayirli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf Serdar","family":"Sakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melik","family":"Seyrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Dogrul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,28]]},"reference":[{"key":"1649_CR1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuroscience.2013.07.035","volume":"250","author":"T Akiyama","year":"2013","unstructured":"Akiyama T, Carstens E (2013) Neural processing of itch. Neuroscience 250:697\u2013714","journal-title":"Neuroscience"},{"key":"1649_CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2013.12.018","volume":"81","author":"WB Anderson","year":"2014","unstructured":"Anderson WB, Gould MJ, Torres RD, Mitchell VA, Vaughan CW (2014) Actions of the dual FAAH\/MAGL inhibitor JZL195 in a murine inflammatory pain model. Neuropharmacology 81:224\u2013230","journal-title":"Neuropharmacology"},{"issue":"8","key":"1649_CR3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","volume":"30","author":"T B\u00edr\u00f3","year":"2009","unstructured":"B\u00edr\u00f3 T, T\u00f3th BI, Hask\u00f3 G, Paus R, Pacher P (2009) The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 30(8):411\u2013420","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"1649_CR4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","volume":"14","author":"JL Blankman","year":"2007","unstructured":"Blankman JL, Simon GM, Cravatt BF (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14(12):1347\u20131356","journal-title":"Chem Biol"},{"issue":"6","key":"1649_CR5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/jm049614v","volume":"48","author":"DL Boger","year":"2005","unstructured":"Boger DL, Miyauchi H, Du W, Hardouin C, Fecik RA, Cheng H, Hwang I, Hedrick MP, Leung D, Acevedo O, Guimar\u00e3es CR, Jorgensen WL, Cravatt BF (2005) Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J Med Chem 48(6):1849\u20131856","journal-title":"J Med Chem"},{"issue":"6690","key":"1649_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A Calignano","year":"1998","unstructured":"Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394(6690):277\u2013281","journal-title":"Nature"},{"issue":"1","key":"1649_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI200316116","volume":"111","author":"ML Casanova","year":"2003","unstructured":"Casanova ML, Bl\u00e1zquez C, Mart\u00ednez-Palacio J, Villanueva C, Fern\u00e1ndez-Ace\u00f1ero MJ, Huffman JW, Jorcano JL, Guzm\u00e1n M (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111(1):43\u201350","journal-title":"J Clin Invest"},{"issue":"3","key":"1649_CR8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0022-3565(24)37499-3","volume":"285","author":"SA Cook","year":"1998","unstructured":"Cook SA, Lowe JA, Martin BR (1998) CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285(3):1150\u20131156","journal-title":"J Pharmacol Exp Ther"},{"issue":"16","key":"1649_CR9","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","volume":"98","author":"BF Cravatt","year":"2001","unstructured":"Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98(16):9371\u20139376","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1649_CR10","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1096\/fj.07-104877","volume":"22","author":"N Dobrosi","year":"2008","unstructured":"Dobrosi N, T\u00f3th BI, Nagy G, D\u00f3zsa A, G\u00e9czy T, Nagy L, Zouboulis CC, Paus R, Kov\u00e1cs L, B\u00edr\u00f3 T (2008) Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J 22(10):3685\u20133695","journal-title":"FASEB J"},{"issue":"1","key":"1649_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pnpbp.2012.01.007","volume":"38","author":"A Dogrul","year":"2012","unstructured":"Dogrul A, Seyrek M, Yalcin B, Ulugol A (2012) Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception. Prog Neuropsychopharmacol Biol Psychiatry 38(1):97\u2013105","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"1649_CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00011-003-1162-z","volume":"52","author":"M Dvorak","year":"2003","unstructured":"Dvorak M, Watkinson A, McGlone F, Rukwied R (2003) Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 52(6):238\u2013245","journal-title":"Inflamm Res"},{"issue":"1","key":"1649_CR13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","volume":"313","author":"D Fegley","year":"2005","unstructured":"Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313(1):352\u2013358","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1649_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/nmo.12272","volume":"26","author":"J Fichna","year":"2014","unstructured":"Fichna J, Sa\u0142aga M, Stuart J, Saur D, Sobczak M, Zatorski H, Timmermans JP, Bradshaw HB, Ahn K, Storr MA (2014) Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. Neurogastroenterol Motil 26(4):470\u2013481","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"1649_CR15","first-page":"111","volume":"354","author":"S Ghosh","year":"2015","unstructured":"Ghosh S, Kinsey SG, Liu QS, Hruba L, McMahon LR, Grim TW, Merritt CR, Wise LE, Abdullah RA, Selley DE, Sim-Selley LJ, Cravatt BF, Lichtman AH (2015) Full fatty acid amide hydrolase inhibition combined with partial monoacylglycerol lipase inhibition: augmented and e. J Pharmacol Exp sustained antinociceptive effects with reduced cannabimimetic side effects in micTher 354(2):111\u2013120","journal-title":"J Pharmacol Exp sustained antinociceptive effects with reduced cannabimimetic side effects in micTher"},{"issue":"8\u20139","key":"1649_CR16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.lfs.2012.06.020","volume":"92","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wise LE, Chen Y, Gujjar R, Mahadevan A, Cravatt BF, Lichtman AH (2013) The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. Life Sci 92(8\u20139):498\u2013505","journal-title":"Life Sci"},{"issue":"7","key":"1649_CR17","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1476-5381.2010.01192.x","volume":"163","author":"J Guindon","year":"2011","unstructured":"Guindon J, Guijarro A, Piomelli D, Hohmann AG (2011) Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain. Br J Pharmacol 163(7):1464\u20131478","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1649_CR18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","volume":"67","author":"J Guindon","year":"2013","unstructured":"Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG (2013) Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. Pharmacol Res 67(1):94\u2013109","journal-title":"Pharmacol Res"},{"issue":"1","key":"1649_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1152\/jn.00938.2009","volume":"104","author":"J Hachisuka","year":"2010","unstructured":"Hachisuka J, Furue H, Furue M, Yoshimura M (2010) Responsiveness of C neurons in rat dorsal root ganglion to 5-hydroxytryptamine-induced pruritic stimuli in vivo. J Neurophysiol 104(1):271\u2013279","journal-title":"J Neurophysiol"},{"key":"1649_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-biophys-051013-022826","volume":"43","author":"L Han","year":"2014","unstructured":"Han L, Dong X (2014) Itch mechanisms and circuits. Annu Rev Biophys 43:331\u2013355","journal-title":"Annu Rev Biophys"},{"issue":"1\u20132","key":"1649_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000371890","volume":"95","author":"T Haruna","year":"2015","unstructured":"Haruna T, Soga M, Morioka Y, Hikita I, Imura K, Furue Y, Yamamoto M, Imura C, Ikeda M, Yamauchi A, Deguchi M, Shichijo M, Arimura A, Yasui K (2015) S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission. Pharmacology 95(1\u20132):95\u2013103","journal-title":"Pharmacology"},{"issue":"2","key":"1649_CR22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/jpet.115.222836","volume":"353","author":"L Hruba","year":"2015","unstructured":"Hruba L, Seillier A, Zaki A, Cravatt BF, Lichtman AH, Giuffrida A, McMahon LR (2015) Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with \u03949-tetrahydrocannabinol in mice. J Pharmacol Exp Ther 353(2):261\u2013268","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133","key":"1649_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","volume":"67","author":"JL Hylden","year":"1980","unstructured":"Hylden JL, Wilcox GL (1980) Intrathecal morphine in mice: a new technique. Eur J Pharmacol 67(2\u20133):313\u2013316","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1649_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.sder.2011.04.001","volume":"30","author":"A Ikoma","year":"2011","unstructured":"Ikoma A, Cevikbas F, Kempkes C, Steinhoff M (2011) Anatomy and neurophysiology of pruritus. Semin Cutan Med Surg 30(2):64\u201370","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"1649_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuropharm.2008.04.018","volume":"55","author":"MD Jhaveri","year":"2008","unstructured":"Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, Sagar DR, Bennett AJ, Alexander SP, Kendall DA, Barrett DA, Chapman V (2008) Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology 55(1):85\u201393","journal-title":"Neuropharmacology"},{"issue":"19","key":"1649_CR26","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1523\/JNEUROSCI.6058-10.2011","volume":"31","author":"Z Justinov\u00e1","year":"2011","unstructured":"Justinov\u00e1 Z, Yasar S, Redhi GH, Goldberg SR (2011) The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys. J Neurosci 31(19):7043\u20137048","journal-title":"J Neurosci"},{"issue":"5830","key":"1649_CR27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1126\/science.1142265","volume":"316","author":"M Karsak","year":"2007","unstructured":"Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, T\u00fcting T, Zimmer A (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316(5830):1494\u20131497","journal-title":"Science"},{"issue":"1","key":"1649_CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plipres.2012.10.003","volume":"52","author":"AC Kendall","year":"2013","unstructured":"Kendall AC, Nicolaou A (2013) Bioactive lipid mediators in skin inflammation and immunity. Prog Lipid Res 52(1):141\u2013164","journal-title":"Prog Lipid Res"},{"issue":"3","key":"1649_CR29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","volume":"330","author":"SG Kinsey","year":"2009","unstructured":"Kinsey SG, Long JZ, O\u2019Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH (2009) Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther 330(3):902\u2013910","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"1649_CR30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbadis.2014.02.007","volume":"1842","author":"AE Kremer","year":"2014","unstructured":"Kremer AE, Feramisco J, Reeh PW, Beuers U, Oude Elferink RP (2014) Receptors, cells and circuits involved in pruritus of systemic disorders. Biochim Biophys Acta 1842(7):869\u2013892","journal-title":"Biochim Biophys Acta"},{"key":"1649_CR31","first-page":"28","volume":"5","author":"BK Lau","year":"2014","unstructured":"Lau BK, Vaughan CW (2014) Targeting the endogenous cannabinoid system to treat neuropathic pain. Front Pharmacol 5:28","journal-title":"Front Pharmacol"},{"issue":"1","key":"1649_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","volume":"5","author":"JZ Long","year":"2009","unstructured":"Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pav\u00f3n FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF (2009) Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5(1):37\u201344","journal-title":"Nat Chem Biol"},{"issue":"48","key":"1649_CR33","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","volume":"106","author":"JZ Long","year":"2009","unstructured":"Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci USA 106(48):20270\u201320275","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1649_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","volume":"35","author":"M Maccarrone","year":"2015","unstructured":"Maccarrone M, Bab I, B\u00edr\u00f3 T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A (2015) Endocannabinoid signaling at the periphery: 50\u00a0years after THC. Trends Pharmacol Sci 35(5):277\u2013296","journal-title":"Trends Pharmacol Sci"},{"key":"1649_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuroscience.2014.05.025","volume":"274","author":"HR Moser","year":"2014","unstructured":"Moser HR, Giesler GJ Jr (2014) Itch elicited by intradermal injection of serotonin, intracisternal injection of morphine, and their synergistic interactions in rats. Neuroscience 274:119\u2013127","journal-title":"Neuroscience"},{"issue":"8","key":"1649_CR36","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","volume":"97","author":"GW Neff","year":"2002","unstructured":"Neff GW, O\u2019Brien CB, Reddy KR, Bergasa NV, Regev A, Molina E, Amaro R, Rodriguez MJ, Chase V, Jeffers L, Schiff E (2002) Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease. Am J Gastroenterol 97(8):2117\u20132119","journal-title":"Am J Gastroenterol"},{"issue":"34","key":"1649_CR37","doi-asserted-by":"crossref","first-page":"10784","DOI":"10.1523\/JNEUROSCI.23-34-10784.2003","volume":"23","author":"H Nojima","year":"2003","unstructured":"Nojima H, Simons CT, Cuellar JM, Carstens MI, Moore JA, Carstens E (2003) Opioid modulation of scratching and spinal c-fos expression evoked by intradermal serotonin. J Neurosci 23(34):10784\u2013107890","journal-title":"J Neurosci"},{"issue":"6","key":"1649_CR38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/1570159X13666150612225212","volume":"13","author":"S Ogawa","year":"2015","unstructured":"Ogawa S, Kunugi H (2015) Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase: new targets for future antidepressants. Curr Neuropharmacol 13(6):760\u2013775","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1649_CR39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, B\u00e1tkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58(3):389\u2013462","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1649_CR40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","volume":"52","author":"S Petrosino","year":"2007","unstructured":"Petrosino S, Palazzo E, de Novellis V, Bisogno T, Rossi F, Maione S, Di Marzo V (2007) Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology 52(2):415\u2013422","journal-title":"Neuropharmacology"},{"key":"1649_CR41","doi-asserted-by":"crossref","unstructured":"Ross SE, Hachisuka J, Todd AJ (2014) Spinal microcircuits and the regulation of itch, chapter 20. In: Carstens E, Akiyama T (eds) Itch: mechanisms and treatment. CRC Press, BocaRaton","DOI":"10.1201\/b16573-21"},{"issue":"6","key":"1649_CR42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2010.02.025","volume":"65","author":"SE Ross","year":"2010","unstructured":"Ross SE, Mardinly AR, McCord AE, Zurawski J, Cohen S, Jung C, Hu L, Mok SI, Shah A, Savner EM, Tolias C, Corfas R, Chen S, Inquimbert P, Xu Y, McInnes RR, Rice FL, Corfas G, Ma Q, Woolf CJ, Greenberg ME (2010) Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 65(6):886\u2013898","journal-title":"Neuron"},{"issue":"1","key":"1649_CR43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<8::AID-SYN2>3.0.CO;2-Y","volume":"35","author":"T Rubino","year":"2000","unstructured":"Rubino T, Vigan\u00f2 D, Zagato E, Sala M, Parolaro D (2000) In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments. Synapse 35(1):8\u201314","journal-title":"Synapse"},{"issue":"7","key":"1649_CR44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/nmo.12563","volume":"27","author":"YS Sakin","year":"2015","unstructured":"Sakin YS, Dogrul A, Ilkaya F, Seyrek M, Ulas UH, Gulsen M, Bagci S (2015) The effect of FAAH, MAGL, and Dual FAAH\/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in rodents. Neurogastroenterol Motil 27(7):936\u2013944","journal-title":"Neurogastroenterol Motil"},{"issue":"10","key":"1649_CR45","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.170.10.4953","volume":"170","author":"MT Samson","year":"2003","unstructured":"Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H (2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170(10):4953\u20134962","journal-title":"J Immunol"},{"key":"1649_CR46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2014.04.006","volume":"734","author":"J Sawynok","year":"2014","unstructured":"Sawynok J, Liu J (2014) Contributions of peripheral, spinal, and supraspinal actions to analgesia. Eur J Pharmacol 734:114\u2013121","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1649_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.108.150136","volume":"329","author":"JE Schlosburg","year":"2009","unstructured":"Schlosburg JE, Boger DL, Cravatt BF, Lichtman AH (2009) Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus. J Pharmacol Exp Ther 329(1):314\u2013323","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1649_CR48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00213-011-2224-5","volume":"216","author":"JE Schlosburg","year":"2011","unstructured":"Schlosburg JE, O\u2019Neal ST, Conrad DH, Lichtman AH (2011) CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action. Psychopharmacology 216(3):323\u2013331","journal-title":"Psychopharmacology"},{"key":"1649_CR49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pbb.2014.05.022","volume":"124","author":"A Seillier","year":"2014","unstructured":"Seillier A, Dominguez Aguilar D, Giuffrida A (2014) The dual FAAH\/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. Pharmacol Biochem Behav 124:153\u2013159","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"1649_CR50","first-page":"457","volume":"21","author":"A Slominski","year":"2000","unstructured":"Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21(5):457\u2013487","journal-title":"Endocr Rev"},{"key":"1649_CR51","doi-asserted-by":"crossref","unstructured":"Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, Slominski RM, Steketee JD (2012) Sensing the environment: regulation of local and global homeostasis by the skin\u2019s neuroendocrine system. Adv Anat Embryol Cell Biol 212:v, vii, 1\u2013115","DOI":"10.1007\/978-3-642-19683-6_1"},{"issue":"4","key":"1649_CR52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuropharm.2012.05.032","volume":"63","author":"JM Spradley","year":"2012","unstructured":"Spradley JM, Davoodi A, Gee LB, Carstens MI, Carstens E (2012) Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin. Neuropharmacology 63(4):743\u2013749","journal-title":"Neuropharmacology"},{"issue":"9","key":"1649_CR53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00105-006-1180-1","volume":"57","author":"S St\u00e4nder","year":"2006","unstructured":"St\u00e4nder S, Reinhardt HW, Luger TA (2006) Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus. Hautarzt 57(9):801\u2013807","journal-title":"Hautarzt"},{"issue":"3","key":"1649_CR54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2011.11.009","volume":"129","author":"K Sugawara","year":"2012","unstructured":"Sugawara K, B\u00edr\u00f3 T, Tsuruta D, T\u00f3th BI, Kromminga A, Z\u00e1k\u00e1ny N, Zimmer A, Funk W, Gibbs BF, Zimmer A, Paus R (2012) Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol 129(3):726\u2013738","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1649_CR55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215(1):89\u201397","journal-title":"Biochem Biophys Res Commun"},{"key":"1649_CR56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/978-1-4612-4974-0_9","volume-title":"Manual of Pharmacologic Calculations with Computer Programs","author":"RJ Tallarida","year":"1987","unstructured":"Tallarida RJ, Murray RB (1987) Manual of Pharmacologic Calculations with Computer Programs, 2nd edn. Springer-Verlag, New York, pp 26\u201331","edition":"2"},{"issue":"13","key":"1649_CR57","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1096\/fj.06-7689com","volume":"21","author":"A Telek","year":"2007","unstructured":"Telek A, B\u00edr\u00f3 T, Bod\u00f3 E, T\u00f3th BI, Borb\u00edr\u00f3 I, Kunos G, Paus R (2007) Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J 21(13):3534\u20133541","journal-title":"FASEB J"},{"issue":"3","key":"1649_CR58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00702-014-1251-x","volume":"122","author":"NC Tosun","year":"2015","unstructured":"Tosun NC, Gunduz O, Ulugol A (2015) Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase. J Neural Transm 122(3):363\u2013367","journal-title":"J Neural Transm"},{"issue":"23","key":"1649_CR59","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SR (2014) Adverse health effects of marijuana use. N Engl J Med 370(23):2219\u20132227","journal-title":"N Engl J Med"},{"key":"1649_CR60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2015.02.004","volume":"93","author":"DM Walentiny","year":"2015","unstructured":"Walentiny DM, Vann RE, Wiley JL (2015) Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Neuropharmacology 93:237\u2013242","journal-title":"Neuropharmacology"},{"issue":"10","key":"1649_CR61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s000110050213","volume":"46","author":"E Weisshaar","year":"1997","unstructured":"Weisshaar E, Ziethen B, Gollnick H (1997) Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm Res 46(10):412\u2013416","journal-title":"Inflamm Res"},{"issue":"8","key":"1649_CR62","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1476-5381.2012.02179.x","volume":"167","author":"SG Woodhams","year":"2012","unstructured":"Woodhams SG, Wong A, Barrett DA, Bennett AJ, Chapman V, Alexander SP (2012) Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat. Br J Pharmacol 167(8):1609\u20131619","journal-title":"Br J Pharmacol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1649-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-016-1649-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1649-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T22:34:12Z","timestamp":1748903652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-016-1649-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,28]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1007\/s00403-016-1649-4","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2016,4,28]]}}}